Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueGross ProfitShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Creative Medical Technology Holdings (CELZ) Cost of Revenue (2017 - 2025)

Creative Medical Technology Holdings has reported Cost of Revenue over the past 9 years, most recently at $994.0 for Q4 2025.

  • Quarterly Cost of Revenue fell 17.17% to $994.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2194.0 through Dec 2025, down 50.14% year-over-year, with the annual reading at $2194.0 for FY2025, 50.14% down from the prior year.
  • Cost of Revenue was $994.0 for Q4 2025 at Creative Medical Technology Holdings, down from $1200.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $39449.0 in Q4 2021 and troughed at $994.0 in Q4 2025.
  • The 5-year median for Cost of Revenue is $3600.0 (2021), against an average of $7219.5.
  • Biggest five-year swings in Cost of Revenue: surged 393.11% in 2021 and later crashed 85.55% in 2022.
  • Tracing CELZ's Cost of Revenue over 5 years: stood at $39449.0 in 2021, then crashed by 85.55% to $5700.0 in 2022, then plummeted by 78.95% to $1200.0 in 2023, then changed by 0.0% to $1200.0 in 2024, then fell by 17.17% to $994.0 in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $994.0, $1200.0, and $1200.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.